1. Home
  2. ATRO vs QURE Comparison

ATRO vs QURE Comparison

Compare ATRO & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astronics Corporation

ATRO

Astronics Corporation

HOLD

Current Price

$74.15

Market Cap

3.5B

Sector

Industrials

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$50.80

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATRO
QURE
Founded
1968
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.2B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
ATRO
QURE
Price
$74.15
$50.80
Analyst Decision
Strong Buy
Buy
Analyst Count
2
14
Target Price
$86.00
$45.00
AVG Volume (30 Days)
642.7K
1.3M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
276.09
29.67
EPS
1.31
N/A
Revenue
$862,128,000.00
$13,107,000.00
Revenue This Year
$14.92
$126.12
Revenue Next Year
$8.81
$200.43
P/E Ratio
$57.06
N/A
Revenue Growth
8.39
N/A
52 Week Low
$35.58
$8.73
52 Week High
$99.89
$71.50

Technical Indicators

Market Signals
Indicator
ATRO
QURE
Relative Strength Index (RSI) 47.24 64.03
Support Level $66.72 $39.50
Resistance Level $77.79 $50.47
Average True Range (ATR) 5.19 1.94
MACD -0.86 0.05
Stochastic Oscillator 12.13 82.59

Price Performance

Historical Comparison
ATRO
QURE

About ATRO Astronics Corporation

Astronics Corporation is a provider of technologies to the aerospace, defense, and electronics industries, offering high-performance electrical power generation and distribution systems, motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. The company operates through two reportable segments, Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the aerospace and defense industry and generates the majority of revenue, while the Test Systems segment designs, develops, manufactures, and maintains automated test systems for the aerospace and defense, communications, and mass transit industries. The company derives the majority of its revenue from the United States.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: